Becton, Dickinson and Company (BDX) said Friday it released an updated cloud platform featuring an artificial intelligence tool to automate experimental panel design for cancer research.
The system uses a specific algorithm to provide design suggestions for researchers to help ensure study results are reliable, the company said.
The software also assists with team cooperation and tracks laboratory duties like buying supplies or checking equipment health, BD said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.